Most FMV programs start with a rate table and stop there. That is not a methodology. It is a number without a defensible rationale.

NorthStar builds FMV frameworks from the ground up: custom tiering criteria, rate structures grounded in published national compensation data, and documentation designed to withstand audit scrutiny. Every assessment follows a consistent, repeatable methodology that ties the final number to verifiable data sources and a transparent analytical framework.

What we deliver:

Custom FMV methodology builds for advisory boards, speaker programs, consulting engagements, and steering committees. Individual HCP rate assessments with tiering based on qualifications, therapeutic area expertise, and national prominence. Rate cards calibrated to published survey data from MGMA, SullivanCotter, AAMC, and specialty association compensation surveys. Audit-defensible documentation for every assessment, structured for OIG and DOJ presentation. Ongoing rate card maintenance and annual refresh recommendations.

By the numbers:

104+ HCP fair market value assessments completed across oncology, cardiology, immunology, sleep medicine, and rare disease. Methodology independently built and validated, not reliant on any single proprietary data source.

Who this is for:

Pre-commercial and early-commercial pharma and biotech companies preparing for first advisory board, first speaker program, or first consulting engagement. Companies that have outgrown a single rate table and need a defensible, scalable FMV program.